Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

361
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
361
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

37
Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least...
37
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

68
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
68
Parametric Survival Analysis: Weibull and Exponential Methods01:14

Parametric Survival Analysis: Weibull and Exponential Methods

418
Parametric survival analysis models survival data by assuming a specific probability distribution for the time until an event occurs. The Weibull and exponential distributions are two of the most commonly used methods in this context, due to their versatility and relatively straightforward application.
Weibull Distribution
The Weibull distribution is a flexible model used in parametric survival analysis. It can handle both increasing and decreasing hazard rates, depending on its shape parameter...
418
Distributions to Estimate Population Parameter01:26

Distributions to Estimate Population Parameter

4.1K
The accurate values of population parameters such as population proportion, population mean, and population standard deviation (or variance) are usually unknown. These are fixed values that can only be estimated from the data collected from the samples. The estimates of each of these parameters are sample proportion, the sample mean, and sample standard deviation (or variance). To obtain the values of these sample statistics, data are required that have particular distribution and central...
4.1K
Confounding in Epidemiological Studies01:27

Confounding in Epidemiological Studies

164
Confounding in statistical epidemiology represents a pivotal challenge, referring to the distortion in the perceived relationship between an exposure and an outcome due to the presence of a third variable, known as a confounder. This variable is associated with both the exposure and the outcome but is not a direct link in their causal chain. Its presence can lead to erroneous interpretations of the exposure's effect, either exaggerating or underestimating the true association. This...
164

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Income-Related Inequalities in Vision Difficulty Among US Adults, 1999-2018.

American journal of ophthalmology·2025
Same author

Disparities in Cardiovascular Disease Prevalence by Race and Ethnicity, Socioeconomic Status, Urbanicity, and Social Determinants of Health Among Medicare Beneficiaries With Diabetes.

Preventing chronic disease·2025
Same author

Changes in Utilization and Expenditures Among Commercially Insured U.S. Adults With Diabetes During the COVID-19 Pandemic: Preliminary Findings.

AJPM focus·2024
Same author

Regional and rural-urban patterns in the prevalence of diagnosed hypertension among older U.S. adults with diabetes, 2005-2017.

BMC public health·2024
Same author

Prevalence of Testing for Diabetes Among US Adults With Overweight or Obesity, 2016-2019.

Preventing chronic disease·2023
Same author

Association Between Hypertension and Diabetes Control and COVID-19 Severity: National Patient-Centered Clinical Research Network, United States, March 2020 to February 2022.

Journal of the American Heart Association·2023

Related Experiment Video

Updated: Jun 25, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K

Modeling County-Level Rare Disease Prevalence Using Bayesian Hierarchical Sampling Weighted Zero-Inflated Regression.

Hui Xie1, Deborah B Rolka1, Lawrence E Barker2

  • 1Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation, Atlanta, Georgia, USA.

Journal of Data Science : JDS
|May 27, 2024
PubMed
Summary
This summary is machine-generated.

A new Bayesian weighted Binomial Zero-inflated (BBZ) model accurately estimates rare disease prevalence using single-year survey data. This method addresses excess zeros, providing timely county-level insights for public health and medical research.

Keywords:
PLOWexcess zerosincidencepower priorsmall area estimate

More Related Videos

In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.7K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Related Experiment Videos

Last Updated: Jun 25, 2025

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

14.5K
In Vivo Modeling of the Morbid Human Genome using Danio rerio
12:31

In Vivo Modeling of the Morbid Human Genome using Danio rerio

Published on: August 24, 2013

20.7K
A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data
10:46

A Method of Trigonometric Modelling of Seasonal Variation Demonstrated with Multiple Sclerosis Relapse Data

Published on: December 9, 2015

10.7K

Area of Science:

  • Biostatistics
  • Epidemiology
  • Public Health

Background:

  • Accurate county-level disease prevalence estimates are crucial for public health applications.
  • Small-area estimation using survey data is common but faces challenges with rare diseases due to excess zero counts.
  • Traditional methods combining multiple years of data can delay estimates and obscure trends.

Purpose of the Study:

  • To propose a novel Bayesian weighted Binomial Zero-inflated (BBZ) model for estimating county-level rare disease prevalence.
  • To address the issue of excess zeros in survey data for low-prevalence conditions.
  • To enable timely, single-year prevalence estimates for rare diseases.

Main Methods:

  • Developed a Bayesian weighted Binomial Zero-inflated (BBZ) model incorporating a power prior.
  • Accounted for excess zero counts and sampling weights within the model.
  • Evaluated the BBZ model using American Community Survey data and simulated datasets.

Main Results:

  • The BBZ model demonstrated reduced bias and smaller variance compared to standard binomial distribution methods.
  • BBZ effectively handles excess zeros, a common issue in rare disease prevalence estimation.
  • The model successfully utilizes single-year survey data for accurate estimations.

Conclusions:

  • The BBZ model provides a statistically robust and timely method for county-level rare disease prevalence estimation.
  • Timely estimates facilitate prompt identification of areas with high needs and support evaluation of disease trends.
  • This approach aids medical researchers and public health practitioners in understanding and responding to rare disease patterns.